维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

15篇 您的检索式：作者名="Clavio"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study显示文摘	BALLEARI E ROSSI E CLAVIO M	2006	Ann Hematol2006，85，：	1
	2	Unusual intracellular and ex- tracellular crystal inclusions in light chain multiple myeloma 显示文摘	Casciaro S Clavio M Boccaccio P	1999	Haematologica1999，84，11：	1
	3	High efficacy of fludarabine-containingtherapy (FLAG-FLANG) in poor risk acute myeloid leukemia显示文摘	CLAVIO M CARRARA P MIGLINO M	1996	Haematologica1996，81，6：	1
	4	Modulation of ovarian function in female dogs immunized with bovine luteinizing hormone receptor显示文摘	Saxena BB Clavio A Singh M	2002	Reprod Domest Anim2002，37，1：	1
	5	High efficacy of fludarabine containing therapy(FLAG,FLANG) in poor risk acute myeloid leukemia显示文摘	Clavio M Carrara P Miglino M	1996	Haematologica1996，81，：	1
	6	Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients With non-M3 acute myeloid leukaemia: results of a prospective, pilot, muhi-centre trial and comparison with a historical cohort of patients 显示文摘	CLAVIO M VIGNOLO L ALBARELLO A	2007	Br J Haematol2007，138，2：	1
	7	Multiple myeloma in the elderly: Clinical features and response to treatment in 113 patient显示文摘	Clavio M Casciaro S Gatti AM	1996	Haematologica1996，81，：	1
	8	WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia显示文摘	Maurizio Miglino Nicoletta Colombo Gianmatteo Pica Raffaella Grasso Marino Clavio Micaela Bergamaschi Filippo Ballerini Anna Ghiso Chiara Ghiggi Laura Mitscheunig Germana Beltrami Antonia Cagnetta Luana Vignolo Maria Vita Lucchetti Sara Aquino Ivana Pierr	2011	Leukemia & Lymphoma2011，，10：	1
	9	Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes 显示文摘	Balleari E Clavio M Arboscello E	2011	Leuk Res2011，35，11：	1
	10	First line fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual diseaes显示文摘	Clavio M Miglino M Spriano M	1998	Eur J Haematol1998，61，3：	1
	11	High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia 显示文摘	CLAVIO M CARRARA P MIGLINO M	1996	Haernatologica1996，81，6：	1
	12	Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate l risk myelodysplastic syndromes显示文摘	Balleari E Clavio M Arboscello E		0，，11：	1
	13	De novo AML patients with favourable-intermediate karyotype may benefit from the addition of lowdose gemtuzumab ozogamicin(GO) to fludarabine,Ara-C and idanubicin(FLAI):a contribution to the reopened 'GO question'显示文摘	Clavio M Cruciani F Minetto P		0，，10：	1
	14	Anaplastic large cell lymphoma: A clinicopathologic study of 53 patients 显示文摘	Rossi E Truini M	1996	Leukemia and lymphoma1996，22，：	1
	15	Quality of life and brain function following high-dose recombinant human erythropoietin in low-risk myelodysplastic syndromes: a preliminary report显示文摘	CLAVIO M NOBILI F BALLEARI E	2004	Eur J Haematol2004，72，2：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费